Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Suzhou No. 3 Pharmaceutical Factory is a prominent Chinese pharmaceutical manufacturer specializing in the production of anti-infective agents, particularly beta-lactam antibiotics. Founded in 1950 and now a subsidiary of China Grand Pharmaceutical and Healthcare Holdings, the company operates large-scale manufacturing facilities for active pharmaceutical ingredients (APIs) and finished dosage forms. Its product portfolio includes a wide range of penicillins and cephalosporins, such as amoxicillin, ampicillin, and cefradine. The company is recognized for its high-quality production standards, holding multiple GMP certifications and exporting products to international markets. It plays a critical role in the supply chain for essential antibiotics both within China and globally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 苏州第三制药厂.